From Childhood to Adulthood: Disease Activity Trajectories in Childhood-Onset Systemic Lupus Erythematosus

被引:17
|
作者
Lim, Lily Siok Hoon [1 ,2 ]
Pullenayegum, Eleanor [3 ]
Feldman, Brian M. [3 ]
Lim, Lillian [3 ]
Gladman, Dafna D. [4 ]
Silverman, Earl D. [3 ]
机构
[1] Univ Manitoba, Winnipeg, MB, Canada
[2] Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada
[3] Hosp Sick Children SickKids, Toronto, ON, Canada
[4] Univ Toronto, Toronto, ON, Canada
基金
加拿大健康研究院;
关键词
ACTIVITY INDEX 2000; PROLONGED REMISSION; COHORT; DAMAGE; OUTCOMES; SLE; CLASSIFICATION; DETERMINANTS; VALIDATION; FREQUENCY;
D O I
10.1002/acr.23319
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. No previous study has studied the longitudinal disease course of childhood-onset systemic lupus erythematosus (cSLE). Our objectives are to assess distinguishable differences in disease activity trajectories in cSLE patients, determine baseline factors predictive of disease trajectory membership, and assess if the different disease activity trajectories are associated with different damage trajectories. Methods. This is a retrospective, longitudinal inception cohort of cSLE patients. Patients were followed from diagnosis as children, until they were adults. SLE disease activity was modeled as a latent characteristic, jointly using the Systemic Lupus Erythematosus Disease Activity Index 2000 and prednisone in a Bayesian growth mixture model. Baseline factors were tested for membership prediction of the latent classes of disease trajectories. Differences in damage trajectories by disease activity classes were tested using a mixed model. Results. A total of 473 patients (82% females), with median age at diagnosis of 14.1 years, were studied. We studied 11,992 visits (2,666 patient-years). We identified 5 classes of disease activity trajectories. Baseline major organ involvement, number of American College of Rheumatology criteria, and age at diagnosis predicted memberships into different classes. A higher proportion of Asians was in class 2 compared to class 5. Class 1 was associated with the most accrual of damage, while class 5 was associated with no significant damage accrual, even after 10 years. Conclusion. There are 5 distinct latent classes of disease trajectory in patients with cSLE. Membership within disease trajectories is predicted by baseline clinical and demographic factors. Membership in different disease activity trajectory classes is associated with different damage trajectories.
引用
收藏
页码:750 / 757
页数:8
相关论文
共 50 条
  • [41] Cognitive Functions In Childhood-Onset Systemic Lupus Erythematosus
    Bellini, Bruna
    de Souza, Cleonice
    Postal, Mariana
    Sinicato, Nailu A.
    Fernandes, Paula T.
    Marini, Roberto
    Appenzeller, Simone
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S531 - S532
  • [42] Rituximab therapy for childhood-onset systemic lupus erythematosus
    Willems, M.
    Haddad, F.
    Niaudet, F.
    Kone-Paut, I.
    Bensman, A.
    Cochat, P.
    Deschenes, G.
    Fakhouri, F.
    Leblanc, T.
    Llanas, B.
    Loirat, C.
    Pillet, F.
    Ranchin, B.
    Salomon, R.
    Ulinski, T.
    Bader-Meunier, Brigitte
    JOURNAL OF PEDIATRICS, 2006, 148 (05): : 623 - 627
  • [43] Social phobia in childhood-onset systemic lupus erythematosus
    Catia Nascimento
    Renata Barbosa
    Luciana Oliveira
    Karina Peliçari
    Nailu Sinicato
    Roberto Marini
    Paula Fernandes
    Simone Appenzeller
    Pediatric Rheumatology, 12 (Suppl 1)
  • [44] Academic Outcomes in Childhood-Onset Systemic Lupus Erythematosus
    Zelko, Frank
    Beebe, Dean
    Baker, Aimee
    Nelson, Shannen M.
    Ali, Aisha
    Cedeno, Adlin
    Dina, Blair
    Klein-Gitelman, Marisa S.
    Ying, Jun
    Brunner, Hermine I.
    ARTHRITIS CARE & RESEARCH, 2012, 64 (08) : 1167 - 1174
  • [45] Neuropsychiatric manifestations in childhood-onset systemic lupus erythematosus
    Appenzeller, Simone
    Pereira, Danilo Rodrigues
    Julio, Paulo Rogerio
    Reis, Fabiano
    Rittner, Leticia
    Marini, Roberto
    LANCET CHILD & ADOLESCENT HEALTH, 2022, 6 (08): : 571 - 581
  • [46] An Update on the Management of Childhood-Onset Systemic Lupus Erythematosus
    Trindade, Vitor Cavalcanti
    Carneiro-Sampaio, Magda
    Bonfa, Eloisa
    Silva, Clovis Artur
    PEDIATRIC DRUGS, 2021, 23 (04) : 331 - 347
  • [47] Pharmacological Management of Childhood-Onset Systemic Lupus Erythematosus
    Thorbinson, Colin
    Oni, Louise
    Smith, Eve
    Midgley, Angela
    Beresford, Michael W.
    PEDIATRIC DRUGS, 2016, 18 (03) : 181 - 195
  • [48] Cost of treatment of childhood-onset systemic lupus erythematosus
    Brunner, HI
    Sherrard, TM
    Klein-Gitelman, MS
    ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2006, 55 (02): : 184 - 188
  • [49] Lupus headaches in childhood-onset systemic lupus erythematosus: relationship to disease activity as measured by the systemic lupus erythematosus disease activity index (SLEDAI) and disease damage
    Brunner, HI
    Jones, OY
    Lovell, DJ
    Johnson, AM
    Alexander, P
    Klein-Gitelman, MS
    LUPUS, 2003, 12 (08) : 600 - 606
  • [50] Childhood-onset Systemic Lupus Erythematosus: neuropsychiatric features and prognostic factors in their transition into adulthood
    Flores Aguilar, Lucia
    Roque Quezada, Juan Carlos
    ANDES PEDIATRICA, 2021, 92 (06): : 985 - 986